Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
Clinical trial NCT02176239 · COMPLETED
Trial details
- NCT number
- NCT02176239
- Sponsor
- BriovaRx Infusion Services
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-01
- Primary completion
- 2019-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.